Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Applying to University of Oklahoma Health Sciences Center · Oklahoma City, Oklahoma
Answer a few short questions to share with the research team.